ASTRAZEN

Astrazeneca Pharma India Ltd.

8,126.00-218.0 (-2.61%)
8 Jul, 12:00 AM

Annual Reports and Financial Documents

Astrazeneca Pharma India Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
2013201420152016201720182019202020212022202320242025
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Astrazeneca Pharma India Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • General6 Jul 2026
    Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Appointment Of Senior Management Personnel (SMP)
    Please find the enclosed intimation of the Company as per the captioned subject for your reference.
  • General16 Jun 2026
    Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Appointment Of Senior Management Personnel
    Please find the enclosed letter of the Company as per the captioned subject for reference.
  • Closure of Trading Window15 Jun 2026
    Closure of Trading Window
    Please find the enclosed intimation of the Company as per the captioned subject for your reference.
  • General12 Jun 2026
    Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Resignation Of Senior Management Personnels
    Please find the enclosed intimation of the Company with respect to the captioned subject for your reference.
  • General11 Jun 2026
    Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015
    Please find the enclosed intimation of the Company as per the captioned subject for review.
  • General4 Jun 2026
    Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
    Please find the enclosed intimation of the Company as per the captioned subject for your reference.
  • General3 Jun 2026
    Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015
    Please find the enclosed intimation of the Company as per the captioned subject for your reference.
  • General1 Jun 2026
    Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Resignation Of Senior Management Personnel
    Please find the enclosed letter of the Company in relation to the captioned subject for your reference.
  • Reg.24(A)-Annual Secretarial Compliance29 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Please find the enclosed report of the Company as per the captioned subject for your reference.
  • Press Release / Media Release26 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Please find the enclosed intimation of the Company as per the captioned subject for your reference.
  • General21 May 2026
    Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015
    Please find the enclosed intimation of the Company as per the captioned subject for reference.
  • General20 May 2026
    Determination Of Materiality - Details Of Key Managerial Personnel
    Please find the enclosed intimation of the Company as per the captioned subject for your reference.
  • Board Meeting20 May 2026
    Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Tuesday, May 26, 2026
    Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve 1. The audited financial ....
  • Amendments to Memorandum & Articles of Association12 May 2026
    Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
    This is in reference to the intimation submitted to the exchange at 1:05 PM under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding ....
  • Amendments to Memorandum & Articles of Association12 May 2026
    Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
    Please find the enclosed intimation of the Company as per the captioned subject for your reference.
  • Postal Ballot12 May 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    Please find the enclosed intimation of the Company as per the captioned subject for your reference.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201829 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Please find the enclosed document as per the captioned subject for your reference.
  • Postal Ballot10 Apr 2026
    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
    Please find the enclosed intimation of the Company as per the captioned subject for your reference.
  • General10 Apr 2026
    Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015
    Please find the enclosed intimation of the Company as per the captioned subject for your reference.
  • General31 Mar 2026
    Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Appointment Of Senior Management Personnel
    Please find the enclosed intimation of the Company as per the captioned subject for your reference.

Frequently Asked Questions

Where can I download the annual report of Astrazeneca Pharma India Ltd.?
Annual reports of Astrazeneca Pharma India Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Astrazeneca Pharma India Ltd.?
Quarterly earnings results and presentations of Astrazeneca Pharma India Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Astrazeneca Pharma India Ltd. publish earnings call transcripts?
Earnings call transcripts of Astrazeneca Pharma India Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Astrazeneca Pharma India Ltd.?
Investor presentations and annual day presentations of Astrazeneca Pharma India Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Astrazeneca Pharma India Ltd.?
Corporate announcements and regulatory filings of Astrazeneca Pharma India Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Astrazeneca Pharma India Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Astrazeneca Pharma India Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Astrazeneca Pharma India Ltd.?
The ISIN (International Securities Identification Number) of Astrazeneca Pharma India Ltd. is INE203A01020. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Astrazeneca Pharma India Ltd. listed?
Astrazeneca Pharma India Ltd. is listed on NSE and BSE. The NSE symbol is ASTRAZEN and the BSE code is -.
Where can I find the shareholding pattern of Astrazeneca Pharma India Ltd.?
The quarterly shareholding pattern of Astrazeneca Pharma India Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Astrazeneca Pharma India Ltd. on Sharpely?
Share price data for Astrazeneca Pharma India Ltd. is updated as of 8 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.